Together, these data indicate that MYD88 and TLRs are heterogeneously expressed in pancreatic cancer, with granulocytes, B cells, and cells of the macrophage/monocyte lineage expressing high levels of TLRs that signal through MyD88. The gene discussed is MYD88; the disease is pancreatic neoplasm.